In a hepatic fibrosis study, Yang et al. (2011) found that complement component 4A in the serum of humans is a biomarker of hepatic fibrosis, with the grade of fibrosis increasing as the level of complement component 4A decreases. This evidence concerns the gene C4A and Hepatic fibrosis.